Highlights: This technical report was prepared by Josh Wurzer, President and Co-Founder of SC Laboratories, Inc, and brought to you by the United Cannabis Business Association (UCBA). This overview report addresses a number of laboratory tests conducted on product samples purchased at unlicensed CBD shops and retailers throughout Los Angeles, California. The samples, all labeled as hemp or hemp-derived products, had the complete California regulatory compliant cannabis test panel performed on them.
SC Laboratories tested 17 samples purchased at unlicensed CBD shops or retailers in the Los Angeles area by the United Cannabis Business Association (UCBA). The samples, all labeled as hemp or hemp-derived products, had the complete California regulatory compliant cannabis test panel performed on them. Over 70% of the samples failed either for excessive contamination or did not qualify as hemp. 42% of the samples failed the safety testing compared with approximately 1.5% of samples that fail for contaminants on the regulated market.
Perhaps more concerning than the overall failure rate, is the level of contamination, which was several hundred times more than allowable limits in some cases. 53% of tested samples labeled as hemp or hemp-based did not qualify, by definition, as hemp. The 2018 Farm bill classifies hemp as cannabis that contains no more than 0.3% total THC.
Furthermore, most of the tested products contained levels of THC sufficient to cause serious psychoactive effects which may be entirely unwanted by CBD users.